Table of Contents

 

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 


 

FORM 10-Q

 


 

x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934

 

For the quarterly period ended June 27, 2008

 

OR

 

o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934

 

For the transition period from                 to                 

 

Commission file number 000-51642

 

Aviza Technology, Inc.

(Exact Name of Registrant as Specified in its Charter)

 

Delaware

 

20-1979646

(State or Other Jurisdiction of Incorporation or Organization)

 

(I.R.S. Employer Identification Number)

 

440 Kings Village Road

Scotts Valley, California   95066

(Address of Principal Executive Offices including Zip Code)

 

(831) 438-2100

(Registrant’s Telephone Number, Including Area Code)

 

Indicate by check mark whether the registrant: (1) has filed all reports required to be filed by Section 13 or 15 (d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.

YES    x      NO    o

 

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See the definitions of “large accelerated filer,” “accelerated filer” and “smaller reporting company” in Rule 12b-2 of the Exchange Act. (Check one):

 

Large accelerated filer     o

Accelerated filer    o

 

 

 

 

Non-accelerated filer    o

Smaller reporting company    x

 

(Do not check if a smaller reporting company)

 

 

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).

YES    o      NO    x

 

As of August 6, 2008, the registrant had 21,856,473 shares of its common stock, par value $0.0001 per share, outstanding.

 

 

 



Table of Contents

 

Aviza Technology, Inc.

 

Table of Contents

 

 

 

Page
No.

PART I. FINANCIAL INFORMATION

 

 

Item 1. Financial Statements (unaudited):

 

 

Condensed Consolidated Balance Sheets — at June 27, 2008 and September 28, 2007

 

1

Condensed Consolidated Statements of Operations —for the Three and Nine Months Ended June 27, 2008 and June 29, 2007

 

2

Condensed Consolidated Statements of Cash Flows — for the Nine Months Ended June 27, 2008 and June 29, 2007

 

3

Notes to Condensed Consolidated Financial Statements

 

4

Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations

 

16

Item 3. Quantitative and Qualitative Disclosures About Market Risk

 

25

Item 4. Controls and Procedures

 

25

 

 

 

PART II. OTHER INFORMATION

 

 

Item 1. Legal Proceedings

 

26

Item 1A. Risk Factors

 

26

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds

 

26

Item 3. Defaults Upon Senior Securities

 

26

Item 4. Submission of Matters to a Vote of Security Holders

 

26

Item 5. Other Information

 

27

Item 6. Exhibits

 

27

 



Table of Contents

 

ITEM 1. FINANCIAL STATEMENTS

 

AVIZA TECHNOLOGY, INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATED BALANCE SHEETS

(in thousands, except par amounts and number of shares)

 

 

 

June 27,

 

September 28,

 

 

 

2008

 

2007 (1)

 

 

 

(Unaudited)

 

 

 

ASSETS

 

 

 

 

 

CURRENT ASSETS:

 

 

 

 

 

Cash and cash equivalents

 

$

11,824

 

$

23,087

 

Accounts receivable - net

 

27,526

 

37,202

 

Inventory

 

45,941

 

45,529

 

Prepaid expenses and other current assets

 

5,128

 

5,317

 

Total current assets

 

90,419

 

111,135

 

 

 

 

 

 

 

PROPERTY, PLANT AND EQUIPMENT - net

 

25,408

 

31,781

 

INTANGIBLE ASSETS - net

 

1,769

 

3,333

 

OTHER ASSETS

 

1,511

 

1,831

 

TOTAL

 

$

119,107

 

$

148,080

 

 

 

 

 

 

 

LIABILITIES AND STOCKHOLDERS’ EQUITY

 

 

 

 

 

 

 

 

 

 

 

CURRENT LIABILITIES:

 

 

 

 

 

Short term borrowings and current portion of notes payable

 

$

28,643

 

$

15,043

 

Accounts payable

 

21,320

 

22,536

 

Warranty liability

 

7,593

 

11,222

 

Accrued liabilities

 

18,729

 

13,391

 

Total current liabilities

 

76,285

 

62,192

 

NOTES PAYABLE - Long term

 

12,295

 

14,490

 

OTHER LIABILITIES - Long term

 

175

 

 

Total liabilities

 

88,755

 

76,682

 

 

 

 

 

 

 

COMMITMENTS AND CONTINGENCIES

 

 

 

 

 

 

 

 

 

 

 

STOCKHOLDERS’ EQUITY:

 

 

 

 

 

Preferred stock, $0.0001 par value - 5,000,000 shares authorized; none outstanding

 

 

 

Common stock, $0.0001 par value—100,000,000 shares authorized; 21,856,473 and 20,846,549 shares issued and outstanding at June 27, 2008 and September 28, 2007, respectively

 

2

 

2

 

Additional paid-in capital

 

121,690

 

118,400

 

Accumulated deficit

 

(94,225

)

(49,974

)

Accumulated other comprehensive income

 

2,885

 

2,970

 

Total stockholders’ equity

 

30,352

 

71,398

 

TOTAL

 

$

119,107

 

$

148,080

 

 


(1)   Amounts were derived from our audited consolidated financial statements for the year ended September 28, 2007 included in our Annual Report on Form 10-K.

 

The accompanying notes are an integral part of these condensed consolidated financial statements.

 

1



Table of Contents

 

AVIZA TECHNOLOGY, INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

(in thousands, except share and per share amounts)

(unaudited)

 

 

 

Quarter Ended

 

Nine Months Ended

 

 

 

June 27,

 

June 29,

 

June 27,

 

June 29,

 

 

 

2008

 

2007

 

2008

 

2007

 

 

 

 

 

 

 

 

 

 

 

NET SALES

 

$

33,505

 

$

57,421

 

$

97,693

 

$

181,251

 

 

 

 

 

 

 

 

 

 

 

COST OF GOODS SOLD:

 

 

 

 

 

 

 

 

 

Cost of goods sold

 

22,490

 

39,246

 

67,808

 

125,304

 

Cost of goods sold - restructuring charges

 

 

 

13,029

 

 

Total cost of goods sold

 

22,490

 

39,246

 

80,837

 

125,304

 

 

 

 

 

 

 

 

 

 

 

GROSS PROFIT

 

11,015

 

18,175

 

16,856

 

55,947

 

 

 

 

 

 

 

 

 

 

 

OPERATING EXPENSES:

 

 

 

 

 

 

 

 

 

Research and development

 

7,337

 

8,101

 

23,357

 

23,815

 

Selling, general and administrative

 

9,001

 

8,217

 

28,084

 

24,846

 

Restructuring and other charges

 

 

 

7,792

 

 

Total operating expenses

 

16,338

 

16,318

 

59,233

 

48,661

 

INCOME (LOSS) FROM OPERATIONS

 

(5,323

)

1,857

 

(42,377

)

7,286

 

 

 

 

 

 

 

 

 

 

 

OTHER INCOME (EXPENSE):

 

 

 

 

 

 

 

 

 

Interest income

 

22

 

146

 

106

 

283

 

Interest expense

 

(487

)

(663

)

(1,435

)

(2,978

)

Other income - net

 

15

 

(449

)

49

 

(425

)

 

 

 

 

 

 

 

 

 

 

Total other expense - net

 

(450

)

(966

)

(1,280

)

(3,120

)

 

 

 

 

 

 

 

 

 

 

INCOME (LOSS) BEFORE INCOME TAXES

 

(5,773

)

891

 

(43,657

)

4,166

 

PROVISION FOR (BENEFIT FROM) INCOME TAXES

 

(128

)

382

 

594

 

1,178

 

 

 

 

 

 

 

 

 

 

 

NET INCOME (LOSS)

 

$

(5,645

)

$

509

 

$

(44,251

)

$

2,988

 

 

 

 

 

 

 

 

 

 

 

Net income (loss) per share:

 

 

 

 

 

 

 

 

 

Basic

 

$

(0.26

)

$

0.02

 

$

(2.05

)

$

0.16

 

Diluted

 

$

(0.26

)

$

0.02

 

$

(2.05

)

$

0.16

 

Weighted average common shares:

 

 

 

 

 

 

 

 

 

Basic

 

21,856,473

 

20,763,221

 

21,590,985

 

18,150,976

 

Diluted

 

21,856,473

 

21,607,161

 

21,590,985

 

18,964,575

 

 

The accompanying notes are an integral part of these condensed consolidated financial statements.

 

2



Table of Contents

 

AVIZA TECHNOLOGY, INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

(in thousands)
(Unaudited)

 

 

 

Nine Months Ended

 

 

 

June 27,

 

June 29,

 

 

 

2008

 

2007

 

CASH FLOWS FROM OPERATING ACTIVITIES:

 

 

 

 

 

Net income (loss)

 

$

(44,251

)

$

2,988

 

Adjustments to reconcile net income (loss) to net cash used in operating activities:

 

 

 

 

 

Depreciation

 

4,045

 

2,908

 

Amortization

 

420

 

945

 

Non-cash restructuring and other charges

 

17,676

 

 

Fair value of common stock issued for prototype materials

 

125

 

 

Stock-based compensation

 

1,451

 

1,530

 

Gain on disposal of equipment

 

(296

)

 

Provision for allowance for doubtful accounts

 

141

 

(19

)

Write-off costs of prior financing agreements

 

 

176

 

Reduction in acquired intangible assets due to the use of acquired net operating losses

 

 

509

 

Changes in assets and liabilities:

 

 

 

 

 

Accounts receivable

 

9,494

 

(13,936

)

Inventory

 

(10,902

)

8,829

 

Prepaid expenses and other assets

 

1,175

 

104

 

Accounts payable

 

(772

)

(11,199

)

Warranty liability

 

(3,593

)

1,104

 

Accrued liabilities

 

5,438

 

1,609

 

Net cash used in operating activities

 

(19,849

)

(4,452

)

 

 

 

 

 

 

CASH FLOWS FROM INVESTING ACTIVITIES:

 

 

 

 

 

Purchases of property, plant and equipment

 

(2,511

)

(7,479

)

Purchase of technology license

 

(48

)

 

Proceeds from sale of equipment

 

324

 

 

Proceeds from sale of the net assets of ET Equipments Ltd.

 

600

 

 

Net cash used in investing activities

 

(1,635

)

(7,479

)

 

 

 

 

 

 

CASH FLOWS FROM FINANCING ACTIVITIES:

 

 

 

 

 

Net proceeds (repayments) on credit lines

 

13,075

 

(12,341

)

Proceeds from the issuance of common stock

 

9

 

27,689

 

Net proceeds on refinancing of mortgage loan

 

 

5,635

 

Proceeds from equipment loan

 

 

4,000

 

Payments on mortgage loan

 

(333

)

(253

)

Payments on other borrowings

 

(985

)

(958

)

Payments on equipment loan

 

(973

)

(95

)

Payments on capital lease obligations

 

(234

)

(195

)

Net cash provided by financing activities

 

10,559

 

23,482

 

Effect of exchange rates on foreign cash balances

 

(338

)

(281

)

NET (DECREASE) INCREASE IN CASH AND CASH EQUIVALENTS

 

(11,263

)

11,270

 

CASH AND CASH EQUIVALENTS:

 

 

 

 

 

Beginning of period

 

23,087

 

10,722

 

End of period

 

$

11,824

 

$

21,992

 

SUPPLEMENTAL DISCLOSURE OF CASH FLOW INFORMATION:

 

 

 

 

 

Cash paid for interest

 

$

1,320

 

$

2,560

 

Cash paid for income taxes

 

$

629

 

$

353

 

NONCASH INVESTING AND FINANCING ACTIVITIES:

 

 

 

 

 

Fair value of common stock issued in the acquisition of technology license

 

$

1,715

 

$

 

Property and equipment purchases included in accounts payable at end of period

 

$

129

 

$

537

 

Equipment acquired under capital lease

 

$

71

 

$

715

 

Notes payable issued for services to be rendered

 

$

 

$

1,737

 

 

The accompanying notes are an integral part of these condensed consolidated financial statements

 

3



Table of Contents

 

AVIZA TECHNOLOGY, INC. AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

June 27, 2008
(Unaudited)

 

1. Basis of Presentation

 

The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with United States (U.S.) generally accepted accounting principles for interim financial information and applicable regulations of the U.S. Securities and Exchange Commission. Certain information and footnote disclosures normally included in financial statements prepared in accordance with accounting principles generally accepted in the U.S. have been condensed or omitted pursuant to such rules and regulations. In the opinion of management, all adjustments (consisting only of normal recurring adjustments) considered necessary for a fair statement of financial position and results of operations have been included. Our operating results for the quarter and nine months ended June 27, 2008 are not necessarily indicative of the results that may be expected for future quarters and the fiscal year ending September 26, 2008. The accompanying unaudited condensed consolidated financial statements should be read in conjunction with our audited consolidated financial statements for the year ended September 28, 2007, which are included in our Annual Report on Form 10-K, and the risk factors contained therein.

 

The preparation of the accompanying unaudited condensed consolidated financial statements requires the use of estimates that affect the reported amounts of assets, liabilities, revenues, expenses and contingencies. These estimates include, but are not limited to, estimates related to revenue recognition, allowance for doubtful accounts, inventory valuation, tangible and intangible long-lived asset valuation, warranty and other obligations, contingent liabilities and litigation. Estimates are updated on an ongoing basis and are evaluated based on historical experience and current circumstances. Changes in facts and circumstances in the future may give rise to changes in these estimates which may cause actual results to differ from current estimates.

 

Aviza Technology, Inc.’s (the “Company” or “Aviza”) current fiscal year will end on September 26, 2008 and includes 52 weeks. We close our fiscal quarters on the last Friday of December, March, June and September.

 

The condensed consolidated financial statements include the accounts of the Company and its subsidiaries. All significant intercompany accounts and transactions have been eliminated in consolidation.

 

4



Table of Contents

 

2. Balance Sheet Details

 

 

 

June 27,

 

September 28,

 

 

 

2008

 

2007

 

 

 

(in thousands)

 

Inventory:

 

 

 

 

 

Raw materials

 

$

28,985

 

$

28,667

 

Work-in-process

 

12,636

 

13,692

 

Finished goods and evaluation systems

 

4,320

 

3,170

 

Total

 

$

45,941

 

$

45,529

 

 

 

 

 

 

 

Prepaid expenses and other current assets:

 

 

 

 

 

Insurance

 

$

375

 

$

96

 

Deferred installation costs

 

249

 

385

 

Taxes

 

2,055

 

2,621

 

Other

 

2,449

 

2,215

 

Total

 

$

5,128

 

$

5,317

 

 

 

 

 

 

 

Property, plant and equipment - net:

 

 

 

 

 

Land

 

$

1,839

 

$

1,839

 

Buildings and improvements

 

12,217

 

12,198

 

Machinery and equipment

 

18,964

 

18,659

 

Office furnishings, fixtures and equipment

 

6,672

 

6,564

 

Construction-in-process

 

758

 

3,820

 

Total

 

40,450

 

43,080

 

Accumulated depreciation

 

(15,042

)

(11,299

)

Property, plant and equipment - net

 

$

25,408

 

$

31,781

 

 

 

 

 

 

 

Accrued liabilities:

 

 

 

 

 

Accrued payroll and payroll taxes

 

$

5,190

 

$

5,660

 

Accrued legal and accounting fees

 

4,618

 

1,643

 

Deferred revenue

 

974

 

1,076

 

Accrued restructuring charges

 

1,646

 

 

Other taxes payable

 

3,455

 

3,557

 

Other

 

2,846

 

1,455

 

Total

 

$

18,729

 

$

13,391

 

 

3. Stock-Based Compensation

 

Effective October 1, 2005, we adopted the provisions of Statement of Financial Accounting Standards, or SFAS, No. 123(R), Share-Based Payment , or SFAS 123(R). SFAS 123(R) establishes standards for the accounting for transactions in which an entity exchanges its equity instruments for goods or services. It also addresses transactions in which an entity incurs liabilities in exchange for goods or services that are based on the fair value of the entity’s equity instruments or that may be settled by the issuance of those equity instruments. Accordingly, stock-based compensation cost is measured at grant date, based on the fair value of the award, and is recognized as expense over the employee’s requisite service period. The measurement of stock-based compensation cost is based on several criteria including, but not limited to, the valuation model used and associated input factors such as expected term of the award, stock price volatility, dividend rate, risk-free interest rate and award cancellation rate. The input factors used in the valuation model are based on subjective future expectations combined with management judgment. If there is a difference between the assumptions used in determining stock-based compensation costs and the actual factors, which become known over time, we may change future input factors used

 

5



Table of Contents

 

in determining stock-based compensation costs. These changes may materially impact our results of operations in the periods over which such costs are expensed.

 

The fair value of each option is estimated at the date of grant using the Black-Scholes option valuation model. We estimate the expected stock price volatility and expected life of our options based on historical data and representative peer group data. We use historical data to estimate forfeiture rates. The risk-free interest rate for periods within the contractual life of the option is based on the U.S. Treasury yield with similar expected life.

 

Under our stock option plans, we may grant options to purchase up to a maximum of 6,644,000 shares of common stock, including outstanding options to employees, directors and consultants at a price not less than the fair market value on the date of the grant. These options generally vest over two to five years and generally expire seven to ten years from the date of the grant.

 

We recognized stock-based compensation expense of $456,000 and $1,451,000 during the quarter and nine months ended June 27, 2008, respectively, and $616,000 and $1,530,000 during the quarter and nine months ended June 29, 2007, respectively. Due to uncertainty surrounding the realization of the income tax benefit related to stock based compensation expense, there is no related income tax benefit recognized in the consolidated statements of operations for the quarter and nine months ended June 27, 2008 and June 29, 2007, respectively, as a full valuation allowance has been provided against the deferred tax asset.

 

The fair value of our stock options granted in the quarter and nine months ended June 27, 2008 and June 29, 2007, respectively, was estimated at the date of grant using the following weighted average assumptions:

 

 

 

Quarter Ended

 

Nine Months Ended

 

 

 

June 27,

 

June 29,

 

June 27,

 

June 29,

 

 

 

2008

 

2007

 

2008

 

2007

 

Expected life (years)

 

3.0

 

4.8

 

3.6

 

4.6

 

Risk-free interest rate

 

2.6%

 

4.6%

 

2.8%

 

4.7%

 

Stock price volatility

 

58.0%

 

60.1%

 

56.3%

 

60.8%

 

Dividend yield

 

0.0%

 

0.0%

 

0.0%

 

0.0%

 

 

6



Table of Contents

 

The following table summarizes our stock option activity under the stock plans during the quarter and nine months ended June 27, 2008 :

 

 

 

 

 

 

 

Weighted Average

 

 

 

 

 

Number of

 

Weighted Average

 

Remaining Contractual

 

Aggregate Intrinsic

 

 

 

Shares

 

Exercise Price

 

Term (Years)

 

Value

 

 

 

 

 

 

 

 

 

 

 

 

 

Outstanding at September 28, 2007

 

4,202,499

 

$

5.01

 

6.51

 

$

3,496,801

 

Granted

 

410,000

 

1.78

 

 

 

 

 

Exercised

 

(9,924

)

0.95

 

 

 

 

 

Forfeited

 

(35,932

)

12.78

 

 

 

 

 

Outstanding at December 28, 2007

 

4,566,643

 

4.66

 

6.27

 

1,266,487

 

Granted

 

100,000

 

1.10

 

 

 

 

 

Exercised

 

 

 

 

 

 

 

Forfeited

 

(78,540

)

9.55

 

 

 

 

 

Outstanding at March 28, 2008

 

4,588,103

 

4.50

 

6.01

 

 

Granted

 

883,500

 

0.52

 

 

 

 

 

Exercised

 

 

 

 

 

 

 

Forfeited

 

(232,346

)

4.52

 

 

 

 

 

Outstanding at June 27, 2008

 

5,239,257

 

3.83

 

5.57

 

 

 

 

 

 

 

 

 

 

 

 

Options vested and expected to vest at June 27, 2008

 

4,948,238

 

3.87

 

5.57

 

 

 

 

 

 

 

 

 

 

 

 

Options vested at June 27, 2008

 

2,904,720

 

4.55

 

5.55

 

 

 

The aggregate intrinsic value represents total pre-tax intrinsic value based on the closing stock price of $0.52, $0.50, $1.81 and $3.45 per share at June 27, 2008, March 28, 2008, December 28, 2007 and September 28, 2007, respectively.

 

As of June 27, 2008, there was $3.2 million of unrecognized compensation cost related to unvested stock options granted and outstanding, net of estimated forfeitures. The cost is expected to be recognized over a weighted average period of approximately 2.4 years.

 

The following table details total stock-based compensation expense for the quarters and nine months ended June 27, 2008 and June 29, 2007, respectively:

 

 

 

Quarter Ended

 

Nine Months Ended

 

 

 

June 27,

 

June 29,

 

June 27,

 

June 29,

 

 

 

2008

 

2007

 

2008

 

2007

 

 

 

(in thousands)

 

Cost of goods sold

 

$

50

 

$

58

 

$

152

 

$

159

 

Research and development

 

110

 

140

 

350

 

363

 

Selling, general and administrative

 

296

 

418

 

949

 

1,008

 

 

 

 

 

 

 

 

 

 

 

Pre-tax stock-based compensation expense

 

456

 

616

 

1,451

 

1,530

 

Income tax benefits

 

 

 

 

 

Stock-based compensation expense

 

$

456

 

$

616

 

$

1,451

 

$

1,530

 

 

7



Table of Contents

 

The options outstanding and vested at June 27, 2008 were in the following exercise price ranges:

 

 

 

Options Outstanding

 

Options Vested

 

 

 

 

 

Weighted

 

 

 

 

 

 

 

 

 

 

 

Average

 

Weighted

 

 

 

Weighted

 

Range of

 

 

 

Remaining

 

Average

 

Number

 

Average

 

Exercise

 

Number

 

Contractual

 

Exercise

 

Vested and

 

Exercise

 

Prices

 

Outstanding

 

Life (Years)

 

Price

 

Exercisable

 

Price

 

 

 

 

 

 

 

 

 

 

 

 

 

$0.52 - $0.54

 

849,541

 

4.86

 

$

0.52

 

33,571

 

$

0.52

 

$0.55 - $0.83

 

1,091,868

 

5.52

 

0.83

 

1,091,830

 

0.83

 

$0.84 - $4.98

 

1,746,589

 

5.13

 

3.49

 

776,000

 

3.59

 

$4.99 - $87.07

 

1,551,259

 

6.48

 

8.14

 

1,003,319

 

9.47

 

$0.52 - $87.07

 

5,239,257

 

5.57

 

3.83

 

2,904,720

 

4.55

 

 

The weighted average fair value of options on the grant date, as determined under SFAS 123(R), granted during the quarter and nine months ended June 27, 2008 was $0.21 and $0.42 per share, respectively, and $3.21 and $3.07 per share for the quarter and nine months ended June 29, 2007, respectively.

 

The total intrinsic value of options exercised during the quarter and nine months ended June 27, 2008 was $0 and $14,000 respectively, and $129,000 and $419,000 for the quarter and nine months ended June 29, 2007, respectively. The total cash received from employees as a result of employee stock options exercises during the quarter and nine months ended June 27, 2008 was $0 and $9,000, respectively. For the quarter and nine months ended June 29, 2007, the total cash received from employees as a result of stock option exercise was $56,000 and $216,000, respectively.

 

4. Intangible Assets

 

 During the quarter ended December 28, 2007, we acquired prototype materials and a license to certain technology in exchange for 1,000,000 shares of our common stock and potential future royalty payments based on net revenue generated from future sales of products developed utilizing the technology. A summary of the total consideration given at closing is as follows (in thousands):

 

Issuance of common stock (1,000,000 shares at $1.83 per share)

 

$

1,830

 

Direct acquisition costs

 

58

 

Total consideration

 

$

1,888

 

 

The price per share used for valuation purposes was the closing price per common share per the NASDAQ Global Market on December 7, 2007, the date the shares were transferred. Direct acquisition costs represent legal costs and use tax liability accrued on the transaction.

 

The total consideration issued in the transaction was allocated based on the estimated fair values of the assets acquired as of the closing date. The allocation is as follows (in thousands):

 

License

 

$

1,763

 

Prototype materials

 

125

 

Total consideration

 

$

1,888

 

 

8



Table of Contents

 

The prototype materials were expensed as research and development costs during the quarter ended December 28, 2007. The cost of the license is being amortized over its estimated 10-year useful life commencing January 2008.

 

Intangible assets are recorded at cost, net of accumulated amortization, and are amortized over their estimated useful lives using the straight-line method. At June 27, 2008 and September 28, 2007 our intangible assets consisted of licenses which we have acquired.

 

We evaluate intangible assets for indicators of possible impairment when events or changes in circumstances indicate the carrying amount of the asset may not be recoverable. During March 2008, we successfully completed testing of new technology which provides a more efficient and cost-effective solution than certain technology we had previously licensed. As a result, the value of the previously licensed technology became impaired. The previously licensed technology was written down to its fair value at March 28, 2008 based upon an analysis of future cash flows related to the technology. This resulted in an impairment charge to operations of approximately $3.0 million which was included in restructuring and other charges during the quarter ended March 28, 2008. The estimated useful life of the previously licensed technology was reduced to one year from March 28, 2008 based on our analysis. The net book value of this license at June 27, 2008 was $94,000, which reflects the write-down.

 

Accumulated amortization and impairment on our intangible assets at June 27, 2008 and September 28, 2007 was $3,994,000 and $858,000, respectively.

 

Amortization expense relating to all intangible assets was $75,000 and $319,000 for the quarter and nine months ended June 27, 2008, respectively, and $116,000 and $369,000 for the quarter and nine months ended June 29, 2007, respectively. Based on the intangible assets recorded at June 27, 2008, and assuming no subsequent additions to or impairment of the underlying assets, the remaining amortization expense is expected to be as follows (in thousands):

 

September 26, 2008 (remaining 3 months)

 

$

75

 

September 25, 2009

 

239

 

September 24, 2010

 

176

 

September 30, 2011

 

176

 

September 28, 2012

 

176

 

Thereafter

 

927

 

Total

 

$

1,769

 

 

9



Table of Contents

 

5. Borrowing Facilities

 

Borrowings consist of the following (in thousands):

 

 

 

June 27,

 

September 28,

 

 

 

2008

 

2007

 

Bank loan (revolving line of credit)

 

$

26,012

 

$

12,937

 

Equipment note payable

 

2,630

 

3,603

 

Mortgage note payable

 

11,452

 

11,785

 

Other notes payable

 

371

 

572

 

Capital lease obligations

 

473

 

636

 

Total

 

40,938

 

29,533

 

Less: short-term and current portion of long-term borrowings

 

28,643

 

15,043

 

Long-term portion

 

$

12,295

 

$

14,490

 

 

6. Warranty and Guarantees

 

Warranty —We accrue for the estimated cost of the warranty on our systems, which includes the cost of the labor and parts necessary to repair systems during the warranty period. The amounts recorded in the warranty accrual are estimated based on actual historical costs incurred and on estimated probable future expenses related to current sales. The warranty accrual is adjusted over the warranty period based on actual cost incurred. Systems typically have warranty periods ranging from one to three years. The components of the warranty accrual are as follows:

 

 

 

Quarter Ended

 

Nine Months Ended

 

 

 

June 27,

 

June 29,

 

June 27,

 

June 29,

 

 

 

2008

 

2007

 

2008

 

2007

 

 

 

(in thousands)

 

Beginning warranty accrual

 

$

8,575

 

$

12,903

 

$

11,222

 

$

10,816

 

Additional accruals for new shipments

 

890

 

2,484

 

2,058

 

8,248

 

Warranty costs incurred

 

(1,317

)

(2,806

)

(5,314

)

(6,560

)

Expiration and change in liability for pre-existing warranties during the period

 

(555

)

(556

)

(373

)

(479

)

Ending warranty accrual

 

$

7,593

 

$

12,025

 

$

7,593

 

$

12,025

 

 

Guarantees —In addition to product warranties, we, from time to time, in the normal course of business, indemnify certain customers against third-party claims that our products, when used for their intended purposes, infringe the intellectual property rights of such third party or other claims made against certain parties. It is not possible to determine the maximum potential amount of liability under these indemnification obligations due to the limited history of prior indemnification claims and the unique facts and circumstances that are likely to be involved in each particular claim. Historically, we have never made payments under these obligations, accordingly no liabilities have been recorded for these obligations on the balance sheet at June 27, 2008 and September 28, 2007, respectively.

 

7. Income Taxes

 

As part of the process of preparing our financial statements, we are required to estimate our income tax provision (benefit) in each of the jurisdictions in which we operate. This process requires us to estimate our current income tax provision (benefit) and assess temporary differences resulting from differing treatment of items for tax and accounting purposes. These differences result in deferred tax assets and liabilities, which are included in our balance sheet .

 

10



Table of Contents

 

We record a valuation allowance to reduce our deferred tax assets to the amount that is more likely than not to be realized. While we have considered future taxable income and any ongoing prudent and feasible tax planning strategies in assessing the need for the valuation allowance, if we were to determine that we would be able to realize our deferred tax assets in the future in excess of our net recorded amount, an adjustment to the deferred tax asset would increase income in the period such determination was made. Likewise, if we were to determine that we would not be able to realize all or part of a net deferred tax asset in the future, an adjustment to the deferred tax asset would be charged to income in the period such determination was made. We have recorded a 100% valuation allowance against our domestic and United Kingdom net deferred tax asset due to the uncertainty regarding future taxable income.

 

 Income tax expense primarily relates to our foreign operations as we continue to incur losses from domestic operations. We recorded an income tax benefit of $128,000 during the quarter ended June 27, 2008 and income tax expense of $594,000 during the nine months ended June 27, 2008. We recorded income tax expense of $382,000 and $1,178,000 for the quarter and nine months ended June 29, 2007, respectively.

 

 We adopted the provisions of Financial Standards Accounting Board Interpretation No. 48, “ Accounting for Uncertainty in Income Taxes ” (“FIN 48”), an interpretation of FASB Statement No. 109 (“SFAS 109”) on September 29, 2007. As a result of the implementation of FIN 48, we recognized no material adjustment in the liability for unrecognized income tax benefits. At the adoption date of September 29, 2007, we had approximately $3.5 million of unrecognized tax benefits, $2.1 million of which would affect our effective tax rate if recognized, and $1.4 million would be offset by valuation allowance. At June 27, 2008, we had $3.6 million of unrecognized tax benefits.

 

 In addition, we recognized interest and penalties related to uncertain tax positions in income tax expense. At the adoption date of September 29, 2007, we had approximately $124,000 of accrued interest and penalties for uncertain tax positions primarily from our foreign operations. We do not anticipate that total unrecognized tax benefits will significantly change due to the settlement of audits and the expiration of the statue of limitations prior to June 26, 2009.

 

 At September 28, 2007, we had approximately $56.6 million and $8.3 million of federal and California net operating loss carryforwards, respectively. We and our subsidiaries have had multiple ownership changes, as defined by Section 382 of the Internal Revenue Code (IRC), due to significant stock transactions in previous years that will limit the future realization of our net operating loss carryforwards. Section 382 will result in the forfeiture of approximately $24.6 million of net operating loss carryforwards for federal income tax purposes. The net operating loss carryforwards begin to expire in 2014 for federal and 2013 for California purposes.

 

 As of September 28, 2007, we had federal and California research and development tax credit carryforwards of approximately $1.7 million and $1.6 million, respectively. Due to Section 382 ownership changes under IRC Section 383, $1.1 million of the federal research tax credit carryforwards will be subject to forfeiture. Federal research and development tax credit carryforwards will expire beginning in fiscal 2011. California research and development tax credits will carry forward indefinitely.

 

8. Restructuring and Other Charges

 

Restructuring Charges - During the quarter ended March 28, 2008, we announced our plans for a significant global restructuring based on an analysis of our product strategy, served markets and internal operations. In order to streamline our operations and align product offerings with the current market conditions, we have and will continue to downsize programs, products and spending related to trench capacitor technology for DRAM and will decrease our overall dependence on the DRAM market. The restructuring of our global workforce, products and business operations was designed to reduce our overall cost structure, as well as improve operational execution and financial performance. We have refocused on our core strengths in the ALD, Etch and PVD technologies, while moving away from the development of large batch thermal systems. We will continue to service and support our current global installed base.

 

As part of our restructuring plans, we executed a global reduction in workforce, divested ourselves of a non-core operation and wrote down assets related to non-core products which included inventory revaluation, cancellation of purchase commitments and the write-down of impaired machinery and equipment. Volume manufacturing will no longer be performed at our Scotts Valley headquarters. Of the restructuring charges, approximately $2.4 million required future cash payments. We estimate these payments will be made throughout fiscal 2009. At June 27, 2008, approximately $1.6 million of these estimated payments remained unpaid and are included in accrued liabilities.

 

11



Table of Contents

 

During the quarter ended March 28, 2008, we sold the net assets of our machine shop, ET Equipments Ltd., located in Wales, UK, for $600,000 as part of our restructuring plan to refocus on our core strengths. The net book value of the net assets sold, cost of completing the transaction and loss on the sale of the net assets of ET Equipments Ltd. were as follows (in thousands):

 

Assets:

 

 

 

 

 

Inventory

 

$

1,143

 

 

 

Equipment

 

148

 

 

 

 

 

 

 

$

1,291

 

Liabilities:

 

 

 

 

 

Accounts payable

 

(19

)

 

 

Accrued liabilities

 

(233

)

 

 

 

 

 

 

(252

)

Net assets sold

 

 

 

1,039

 

Transaction costs

 

 

 

104

 

 

 

 

 

1,143

 

Less: Purchase price

 

 

 

(600

)

Net loss on sale of net assets of ET Equipments Ltd.

 

 

 

$

543

 

 

Transaction costs related primarily to legal fees incurred.

 

Other Charges - During the quarter ended March 28, 2008, we recognized impairment of an intangible asset related to a license we had acquired (see Note 4). Completion of successful testing of a new technology, which provides a more efficient and cost-effective solution, lead to the impairment of the license, resulting in a charge of approximately $3.0 million to operations during the quarter ended March 28, 2008.

 

The impact of these restructuring and other charges on the operating results for the nine months ended June 27, 2008, and the remaining liability as of June 27, 2008, is summarized as follows (in thousands):

 

 

 

 

 

Loss on

 

 

 

Sale of Net

 

Impairment of

 

 

 

 

 

 

 

Reduction in

 

Non-cancellable

 

Inventory

 

Assets of

 

Machinery and

 

Impairment of

 

 

 

 

 

Work Force

 

Purchase Commitments

 

Revaluation

 

ET Equipments Ltd.

 

Equipment (1)

 

Intangible

 

Total

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Restructuring costs - cost of goods sold

 

$

380

 

$

2,178

 

$

10,471

 

$

 

$

 

$

 

$

13,029

 

Restructuring and other charges - operating expenses

 

387

 

 

-

 

543

 

3,854

 

3,008

 

7,792

 

Total restructuring and other charges

 

767

 

2,178

 

10,471

 

543

 

3,854

 

3,008

 

20,821

 

Non-cash adjustments

 

 

 

(10,471

)

(543

)

(3,654

)

(3,008

)

(17,676

)

Cash payments

 

(589

)

(149

)

 

 

 

 

(738

)

Balance at March 28, 2008

 

178

 

2,029

 

 

 

200

 

 

2,407

 

Cash payments

 

(174

)

(587

)

 

 

 

 

(761

)

Balance at June 27, 2008

 

$

4

 

$

1,442

 

$

 

$

 

$

200

 

$

 

$

1,646

 

 


(1) Includes $200,000 of disposal costs accrued as of June 27, 2008

 

12



Table of Contents

 

9. Commitments and Contingencies

 

On April 11, 2006, IPS, Ltd. filed a lawsuit against us in the United States District Court for the Central District of California. The complaint alleges that we improperly used IPS’s confidential information to develop our Celsior single-wafer processing type atomic layer deposition technology. The complaint is for unspecified monetary damages, injunctive relief and an order rescinding the settlement and distributor agreements that we and IPS entered into in May 2004 in settlement of a prior lawsuit that IPS filed against ASML U.S., Inc. and us in March 2004 relating to assets that we acquired from ASML in October 2003. In May 2007, we successfully moved the dispute to arbitration. Discovery commenced in June 2007. The arbitration hearing is currently scheduled for March 2009. We intend to contest the lawsuit vigorously. We do not believe that the outcome of this lawsuit will have a material impact on our business, financial condition or results of operations.

 

Prior to our merger transaction with Trikon Technologies, Inc., Trikon was a party to an employment lawsuit in France. On March 10, 2004, Dr. Jihad Kiwan departed Trikon as Director and Chief Executive Officer. On March 29, 2004 and April 2, 2004, Trikon received letters from a United Kingdom law firm and from a French law firm, respectively, on behalf of Dr. Kiwan, detailing certain monetary claims for severance amounts due to Dr. Kiwan with respect to his employment with Trikon. On April 28, 2004, Dr. Kiwan filed a lawsuit in France and on June 10, 2004, filed similar proceedings in the United Kingdom. Dr. Kiwan has subsequently withdrawn the proceedings in the United Kingdom. On January 7, 2008, the French Commercial Court in Grenoble rejected certain of Dr. Kiwan’s claims but ordered us to pay monetary awards with respect to certain other of Dr. Kiwan’s claims. We intend to appeal the decision and do not believe that the outcome of the dispute will have a material impact on our business, financial condition or results of operations. We have accrued our estimate of the costs to settle the claims at June 27, 2008.

 

On December 1, 2006, we filed an arbitration demand against ASML U.S., Inc., and related entities, asserting claims of fraud, negligent misrepresentation, fraud in the inducement and breach of the covenant of good faith and fair dealing arising out of our purchase of ASML’s Thermal Division in October 2003. Following discovery and an unsuccessful motion for summary judgment filed by ASML, the matter was arbitrated in December 2007 and January 2008. The arbitrator issued a preliminary judgment in favor of ASML. Based on a provision in the governing contract providing that the party prevailing in the arbitration may recover its attorneys’ fees and costs from the opposing party, the arbitrator has ordered briefings by both parties with regard to any fee request by ASML. On April 17, 2008, ASML submitted a petition seeking approximately $2.5 million in attorneys’ fees and costs incurred in connection with this matter. Following full briefing by both parties, the arbitrator issued a final award of approximately $1.4 million in attorneys’ fees and costs to ASML. We have accrued our estimate of the cost to settle the claims at June 27, 2008.

 

Our Scotts Valley location is a federal Superfund site. Chlorinated solvent and other contamination was identified at the site in the early 1980’s, and by the late 1980’s Watkins Johnson Corporation (“WJ”) (a previous owner of the Company) had installed a groundwater extraction and treatment system. In 1991, WJ entered into a consent decree with the United States Environmental Protection Agency providing for remediation of the site. In July 1999, WJ signed a remediation agreement with an environmental consulting firm, ARCADIS Geraghty and Miller (“ARCADIS”). Pursuant to this remediation agreement, WJ paid approximately $3 million in exchange for which ARCADIS agreed to perform the work necessary to assure satisfactory completion of WJ’s obligation under the consent decree. The agreement also includes a cost overrun guaranty from ARCADIS up to a total project cost of $15 million. In addition, the agreement included procurement of a ten-year, claims-made insurance policy to cover overruns of up to $10 million from American International Specialty (“AIS”), along with a ten-year, claims made $10 million policy to cover unknown pollution conditions at the site.

 

Failure of WJ, ARCADIS, or AIS to fulfill their obligations may subject the Company to substantial fines, and the Company could be forced to suspend production, alter manufacturing processes or cease business operations, any of which could have a material negative effect on the Company’s business, financial condition or results of operations.

 

13



Table of Contents

 

Management believes that the likelihood of the failure of WJ, ARCADIS or AIS is remote and that any remaining or uninsured environmental liabilities will not have a material impact on the Company’s business, financial condition or results of operations.

 

10. Major Customers

 

The following chart illustrates the percentages of our net sales accounted for by our largest customers for the periods indicated:

 

 

 

Quarter Ended

 

Nine Months Ended

 

 

 

June 27,

 

June 29,

 

June 27,

 

June 29,

 

Customers

 

2008

 

2007

 

2008

 

2007

 

 

 

 

 

 

 

 

 

 

 

A

 

33

%

20

%

16

%

35

%

B

 

11

%

27

%

 

 

C

 

 

 

10

%

 

 

11. Comprehensive Income (Loss)

 

The components of comprehensive income (loss) are as follows (in thousands):

 

 

 

Quarter Ended

 

Nine Months Ended

 

 

 

June 27,

 

June 29,

 

June 27,

 

June 29,

 

 

 

2008

 

2007

 

2008

 

2007

 

Net income (loss)

 

$

(5,645

)

$

509

 

$

(44,251

)

$

2,988

 

Currency translation adjustment

 

(37

)

404

 

(85

)

1,613

 

 

 

 

 

 

 

 

 

 

 

Total comprehensive (loss) income

 

$

(5,682

)

$

913

 

$

(44,336

)

$

4,601

 

 

12. Net Income (Loss) Per Share

 

Basic income (loss) per share has been computed based upon the weighted average number of common shares outstanding for the periods presented. Diluted income (loss) per share is calculated as though all potentially dilutive shares were outstanding during the period, based upon the application of the treasury stock method. The following details the calculation of the net income (loss) per share for the periods presented (in thousands, except share and per share data):

 

14



Table of Contents

 

 

 

Quarter Ended

 

Nine Months Ended

 

 

 

June 27,

 

June 29,

 

June 27,

 

June 29,

 

 

 

2008

 

2007

 

2008

 

2007

 

 

 

 

 

 

 

 

 

 

 

Numerator:

 

 

 

 

 

 

 

 

 

Net income (loss)

 

$

(5,645

)

$

509

 

$

(44,251

)

$

2,988

 

 

 

 

 

 

 

 

 

 

 

Denominator:

 

 

 

 

 

 

 

 

 

Basic weighted average shares outstanding

 

21,856,473

 

20,763,221

 

21,590,985

 

18,150,976

 

Effect of potentially dilutive securities:

 

 

 

 

 

 

 

 

 

Stock options

 

 

843,940

 

 

813,599

 

Dilutive weighted average shares outstanding

 

21,856,473

 

21,607,161

 

21,590,985

 

18,964,575

 

 

 

 

 

 

 

 

 

 

 

Net income (loss) per share - basic

 

$

(0.26

)

$

0.02

 

$

(2.05

)

$

0.16

 

 

 

 

 

 

 

 

 

 

 

Net income (loss) per share - diluted

 

$

(0.26

)

$

0.02

 

$

(2.05

)

$

0.16

 

 

For the nine months ended June 27, 2008 and June 29, 2007, we had securities outstanding that could potentially dilute basic earnings per share in the future, but were excluded from the computation of diluted net income (loss) per share in the periods presented as their effect would have been anti-dilutive. The weighted average shares of common stock issuable upon conversion or exercise of such outstanding securities consist of the following:

 

 

 

Quarter Ended

 

Nine Months Ended

 

 

 

June 27,

 

June 29,

 

June 27,

 

June 29,

 

 

 

2008

 

2007

 

2008

 

2007

 

 

 

 

 

 

 

 

 

 

 

Options that would have been included in the computation of dilutive shares outstanding had the Company reported net income from continuing operations because the exercise price of such options exceeded the average stock price.

 

 

 

1,486,416

 

 

 

 

 

 

 

 

 

 

 

 

Options that were excluded from the computation of dilutive shares outstanding because the total assumed proceeds exceeded the average market value of the Company’s common stock during the period

 

4,998,451

 

2,261,110

 

3,141,570

 

2,413,741

 

 

 

 

 

 

 

 

 

 

 

Shares issuable upon exercise of common stock warrants

 

290,000

 

406,725

 

300,262

 

406,725

 

 

15



Table of Contents

 

ITEM 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

 

Cautionary Statement Regarding Forward-Looking Statements

 

The statements in this report include forward-looking statements. These forward-looking statements are based on our management’s current expectations and beliefs and involve numerous risks and uncertainties that could cause actual results to differ materially from expectations. You should not rely upon these forward-looking statements as predictions of future events because we cannot assure you that the events or circumstances reflected in these statements will be achieved or will occur. You can identify forward-looking statements by the use of forward-looking terminology, including the words “believes,” “expects,” “may,” “will,” “should,” “seeks,” “intends,” “plans,” “estimates” or “anticipates” or the negative of these words and phrases or other variations of these words and phrases or comparable terminology. These forward-looking statements relate to, among other things: our sales, results of operations and anticipated cash flows; capital expenditures; depreciation and amortization expenses; research and development expenses; sales, general and administrative expenses; the development and timing of the introduction of new products and technologies; our ability to maintain and develop relationships with our existing and potential future customers and our ability to maintain the level of investment in research and development and capacity that is required to remain competitive. Many factors could cause our actual results to differ materially from those projected in these forward-looking statements, including, but not limited to: variability of our revenues and financial performance; risks associated with product development and technological changes; the acceptance of our products in the marketplace by existing and potential future customers; disruption of operations or increases in expenses due to our involvement in litigation or caused by civil or political unrest or other catastrophic events; general economic conditions and conditions in the semiconductor industry in particular; the continued employment of our key personnel and risks associated with competition.

 

For a discussion of the factors that could cause actual results to differ materially from the forward-looking statements, see the “Liquidity and Capital Resources” section under “Management’s Discussion and Analysis of Financial Condition and Results of Operations” in this item of this report and the other risks and uncertainties that are set forth elsewhere in this report or detailed in our other Securities and Exchange Commission reports and filings. We assume no obligation to update these forward-looking statements.

 

Overview

 

We design, manufacture, sell and support advanced semiconductor capital equipment and process technologies for the global semiconductor industry and related markets. We offer both front-end-of-line and back-end-of-line systems and process technologies used in a variety of segments of the semiconductor market using critical thin film formation technologies, including ALD, PVD, CVD, Etch and thermal processing systems.

 

Our customer base is geographically diverse and includes both integrated device manufacturers and foundry-based manufacturers. We have a broad installed base, with approximately 2,500 systems in active operation for which we are providing ongoing parts and services worldwide. We sell our systems globally primarily through a direct sales force and in some instances through local independent sales representatives. Our largest customers may vary from year to year depending upon, among other things, the customer’s annual budget for capital expenditures, plans for new fabrication facilities and expansions and new system introductions by us.

 

Aviza Technology, Inc. was incorporated on December 8, 2004 to facilitate the merger transaction of our subsidiaries, Aviza, Inc. and Trikon Technologies, Inc. Aviza, Inc. was incorporated on September 18, 2003 by affiliates of VantagePoint Venture Partners, or VantagePoint, as Thermal Acquisition Corporation, a Delaware corporation, for the purpose of acquiring the business of the Thermal Division of ASML Holding, N.V., a Netherlands corporation, which division of ASML is referred to in this discussion as the Predecessor. On October 10, 2003, Thermal Acquisition Corporation acquired the business of the Predecessor and changed its name to Aviza Technology, Inc., which name was subsequently changed to Aviza, Inc. in connection with the merger transaction with Trikon.

 

On December 1, 2005, we completed the merger transaction with Trikon, and our common stock is publicly traded on the Nasdaq Global Market under the symbol “AVZA.”

 

16



Table of Contents

 

We are often required to develop systems in advance of our customers’ demand for those systems, and we undertake significant system development efforts in advance of any of our customers expressly indicating demand for our systems. Our system development efforts typically span six months to two years.

 

During the quarter ended March 28, 2008, we announced plans for a global restructuring based upon an analysis of our product strategy, served markets and internal operations. The restructuring allows us to refocus our attention on our core strengths in the ALD, Etch and PVD market segments. We have and will continue to downsize programs, products and spending related to trench capacitor technology for DRAM and will decrease our overall dependence on the DRAM market. The restructuring of our global workforce, products and business operations was designed to reduce our cost structure as well as improve operational execution and financial performance. We will continue to support our current global installed base and maintain the ability to manufacture additional systems as may be required by customers. During the quarter ended March 28, 2008, we recorded approximately $17.8 million in costs associated with the restructuring. These charges were primarily attributable to a global reduction in force of approximately 15% of employees and contractors and the write-down of assets relating to non-core products or processes which include inventory revaluation, cancellation of purchase commitments and the write-down of equipment. Annualized savings as a result of our restructuring related to lower employee costs and lower depreciation expenses will be approximately $8.0 million.

 

On March 28, 2008, we received notification from Nasdaq informing us that the bid price of our common stock closed below the minimum $1.00 per share requirement for continued inclusion under the Market place Rule 4450(a)(5). We have until September 24, 2008 to regain compliance.

 

Critical Accounting Policies

 

There are no material changes to the critical accounting policies described in the section entitled “Critical Accounting Polices” under Item 7 in our Annual Report on Form 10-K for the fiscal year ended September 28, 2007.

 

17



Table of Contents

 

Results of Operations

 

The information in the table below presents our statements of operations data as a percentage of net sales for the quarters and nine months ended June 27, 2008 and June 29, 2007.

 

 

 

Quarter Ended

 

Nine Months Ended

 

 

 

June 27,

 

June 29,

 

June 27,

 

June 29,

 

 

 

2008

 

2007

 

2008

 

2007

 

 

 

 

 

 

 

 

 

 

 

Net sales

 

100

%

100

%

100

%

100

%

Cost of goods sold

 

 

 

 

 

 

 

 

 

Cost of goods sold

 

67

%

68

%

70

%

69

%

Cost of goods sold - restructuring charges

 

0

%

0

%

13

%

0

%

Total cost of sales

 

67

%

68

%

83

%

69

%

Gross margin

 

33

%

32

%

17

%

31

%

 

 

 

 

 

 

 

 

 

 

Operating expenses:

 

 

 

 

 

 

 

 

 

Research and development

 

22

%

14

%

24

%

13

%

Selling, general and administrative

 

27

%

15

%

28

%

14

%

Restructuring and other charges

 

0

%

0

%

8

%

0

%

Total operating expenses

 

49

%

29

%

60

%

27

%

Income (loss) from operations

 

(16

)%

3

%

(43

)%

4

%

Other income (expense):

 

 

 

 

 

 

 

 

 

Interest income

 

0

%

0

%

0

%

0

%

Interest expense

 

(1

)%

(1

)%

(1

)%

(2

)%

Other income - net

 

0

%

0

%

0

%

0

%

Total other expense - net

 

(1

)%

(1

)%

(1

)%

(2

)%

Income (loss) before income taxes

 

(17

)%

2

%

(44

)%

2

%

Provision for income taxes

 

0

%

1

%

1

%

1

%

Net income (loss)

 

(17

)%

1

%

(45

)%

1

%

 

Net Sales

 

 

 

Quarter Ended

 

Nine Months Ended

 

 

 

June 27,

 

June 29,

 

June 27,

 

June 29,

 

 

 

2008

 

2007

 

2008

 

2007

 

 

 

(in thousands)

 

Net sales

 

$

33,505

 

$

57,421

 

$

97,693

 

$

181,251

 

 

Net sales for the quarter ended June 27, 2008 decreased by $23.9 million, or 42%, from the quarter ended June 29, 2007. The decrease was due primarily to the following:

 

·       An approximate $33.4 million decrease in net sales of our deposition and thermal processing systems. Sales recognized on shipment decreased by $28.2 million as unit shipments decreased by 96% during the quarter ended June 27, 2008 from the quarter ended June 29, 2007. Net sales recognized upon customer acceptance decreased by $5.2 million primarily due to a $3.9 million reduction in RVP-300 plus system acceptances, which reflects fewer systems in the field under installation. The overall decrease is the result of changes within our DRAM customers, relating primarily to trench capacitor technology.

 

18



Table of Contents

 

·       The decrease in our deposition and thermal processing systems net sales was partially offset by a $7.7 million (68%) increase in net sales of our PVD, Etch and CVD systems due to higher unit volume through market penetration in the Asia Pacific market.

 

·       Service and spare parts sales increased by approximately $1.7 million during the quarter ended June 27, 2008 due primarily to higher field option sales.

 

Net sales for the nine months ended June 27, 2008 decreased by $83.6 million, or 46%, from the nine months ended June 29, 2007. The decrease was due primarily to the following:

 

·       An approximate $91.9 million decrease in net sales of our deposition and thermal processing systems. Sales recognized on shipment decreased by $81.4 million as unit shipments decreased by 88% during the nine months ended June 27, 2008 as compared to the nine months ended June 27, 2007. Net sales recognized upon customer acceptance decreased by $10.5 million primarily due to an $8.2 million reduction in RVP-300plus system acceptances, which reflect lower unit shipments and completed installation during the period. The decrease was due primarily to market pricing pressures for our DRAM customers and changes relating to trench capacitor technology within our customer group.

 

·       The decrease in the net sales of our deposition and thermal processing systems was partially offset by a $9.4 million increase in net sales of our PVD, Etch, and CVD systems.

 

·       Service and spares sales were approximately 3% less during the nine months ended June 27, 2008 due primarily to lower equipment utilization at our customer sites.

 

During the quarter ended June 27, 2008, Triquent Semiconductor, Inc. accounted for 11% of our net sales. During the quarter and nine months ended June 27, 2008, Win Semiconductor Corporation accounted for 33% and 16% of our net sales, respectively. During the nine months ended June 27, 2008, Qimonda A.G. accounted for 10% of our net sales.

 

During the quarter ended June 29, 2007, Nan Ya Technology Corporation accounted for 27% of our net sales. During the quarter and nine months ended June 29, 2007, Inotera Memories, Inc. accounted for 20% and 35% of our net sales, respectively.

 

Gross Profit and Gross Margin

 

Gross profit is the difference between net sales and cost of goods sold. Cost of goods sold consists of purchased material, labor and overhead to manufacture equipment or spare parts and the cost of service and factory and field support to customers for warranty, installation and paid service calls. In addition, the cost of outsourcing the assembly or manufacturing of systems and subsystems to third parties is included in cost of goods sold. Gross margin is gross profit expressed as a percentage of net sales.

 

 

 

Quarter Ended

 

Nine Months Ended

 

 

 

June 27,

 

June 29,

 

June 27,

 

June 29,

 

 

 

2008

 

2007

 

2008

 

2007

 

 

 

(dollars in thousands)

 

Gross profit

 

$

11,015

 

$

18,175

 

$

16,856

 

$

55,947

 

Gross margin

 

33

%

32

%

17

%

31

%

 

19



Table of Contents

 

Gross margin increased by approximately 1% during the quarter ended June 27, 2008 as compared to the quarter ended June 29, 2007. This increase was primarily the result of the following:

 

·       A shift in the system product mix away from our deposition and thermal processing systems to higher-gross margin PVD, Etch, and CVD systems. During the quarter ended June 27, 2008, PVD, Etch, and CVD systems accounted for approximately 58% of system sales as compared to 20% during the quarter ended June 29, 2007.

 

·       A decrease in unabsorbed manufacturing costs as reductions in manufacturing costs due to implementation of cost cutting measures more than offset lower manufacturing cost absorption due to lower unit volume.

 

These positive impacts on gross margin were partially offset by an 8% reduction in overall service gross margin, which was due primarily to lower installation and warranty activity related to deposition and thermal product lines.

 

The decrease in gross margin of 14% during the nine months ended June 27, 2008 as compared to the nine months ended June 29, 2007 was primarily due to the restructuring charges of approximately $13.0 million recorded during the nine months ended June 27, 2008.

 

Excluding the impact of restructuring charges, gross margin for the nine months ended June 27, 2008 was consistent with gross margin for the nine months ended June 29, 2007. While gross margin was consistent from period to period the changes impacting gross margin during the nine months ended June 27, 2008 as compared to the nine months ended June 29, 2007 were as follows:

 

·       Gross margin recognized on shipment of our systems was approximately 8% higher during the nine months ended June 27, 2008 due to changes in the product mix, with a higher proportion of PVD, Etch, and CVD shipments and a lower proportion of thermal processing systems.

 

·       Gross margin on service-related activities decreased by approximately 10% due to lower spare parts sales, a higher proportion of field option sales during the nine months ended June 27, 2008 and lower demand for installation and warranty services created by lower shipments during the nine months ended June 27, 2008.

 

·       Reductions in manufacturing cost of approximately $6.0 million were more than offset by lower manufacturing cost absorption of $8.5 million due to a decrease in the number of systems produced during the nine months ended June 27, 2008 primarily in relation to an 88% decrease in deposition and thermal system shipments.

 

Research and Development

 

Research and development expense consists of employment costs attributable to employees, consultants and contractors who primarily spend their time on system design, engineering and process development; materials and supplies used in system prototyping, including wafers, chemicals and process gases; depreciation and amortization expense allocable to research and development activities and facilities; direct charges for repairs to research equipment and laboratories; costs of outside services for facilities; and process engineering support and wafer analytical services. We also include in research and development expenses associated with the preparation, filing and prosecution of patents and other intellectual property.

 

 

 

Quarter Ended

 

Nine Months Ended

 

 

 

June 27,

 

June 29,

 

June 27,

 

June 29,

 

 

 

2008

 

2007

 

2008

 

2007

 

 

 

(dollars in thousands)

 

Research and development

 

$

7,337

 

$

8,101

 

$

23,357

 

$

23,815

 

Percent of net sales

 

22

%

14

%

24

%

13

%

 

20



Table of Contents

 

Research and development costs decreased by approximately $0.8 million, or 9%, during the quarter ended June 27, 2008 as compared to the quarter ended June 29, 2007 due primarily to the following:

 

·

 

A 19% reduction in head count contributed to a net decrease of approximately $0.5 million in salaries and benefits.

 

 

 

·

 

A $0.3 million reduction in net prototype supplies related primarily to a next-generation product development project that was in process during the quarter ended June 29, 2007.

 

 

 

·

 

As part of our restructuring plan implemented during fiscal 2008, we deemphasized research and development activity related to thermal products. As a result, our development lab-related costs for supplies, chemicals, gases and prototype supplies related to the thermal products decreased by approximately $0.6 million.

 

 

 

·

 

Increased travel expenses of approximately $0.2 million related to increased PVD, Etch, and CVD opportunities in the Asia Pacific region.

 

 

 

·

 

Approximately $0.2 million increase in depreciation expense and lab equipment rentals.

 

 

 

·

 

An approximate $0.1 million increase in patent-related costs.

 

The net decrease in research and development costs of approximately $0.5 million, or 2%, during the nine months ended June 27, 2008 as compared to the nine months ended June 29, 2007 was primarily due to the following:

 

·

 

A $0.5 million decrease in salaries and benefits related primarily to a reduction in workforce associated with our restructuring plan implemented during the nine months ended June 29, 2008.

 

 

 

·

 

As part of our restructuring plan implemented during fiscal 2008, we deemphasized continued research and development activity related to our thermal product lines. As a result, we reduced costs by approximately $1.4 million through decreased development lab activities.

 

 

 

·

 

Increased depreciation, amortization, and equipment rental expense of approximately $1.0 million related primarily to equipment installed in our development laboratories and amortization of a technology license acquired during December 2007.

 

 

 

·

 

Increased travel expense of approximately $0.3 million related primarily to increased PVD, Etch, and CVD business opportunities in Asia Pacific region.

 

Selling, General and Administrative

 

Selling, general and administrative expense consists of employment costs attributable to employees, consultants and contractors who primarily spend their time on sales, marketing and order administration and corporate administrative services; occupancy costs attributable to employees performing these functions; sales commissions; promotional marketing expenses; and legal and accounting expenses.

 

 

 

Quarter Ended

 

Nine Months Ended

 

 

 

June 27,

 

June 29,

 

June 27,

 

June 29,

 

 

 

2008

 

2007

 

2008

 

2007

 

 

 

(dollars in thousands)

 

Selling, general and administrative

 

$

9,001

 

$

8,217

 

$

28,084

 

$

24,846

 

Percent of net sales

 

27

%

15

%

28

%

14

%

 

21



Table of Contents

 

The increase in selling, general and administrative expense of approximately $0.8 million, or 10%, during the quarter ended June 27, 2008, as compared to the quarter ended June 29, 2007, was primarily due to the following:

 

·       A $1.0 million increase in legal costs associated with pending legal matters.

 

·       An approximate $0.2 million increase in third-party commissions due to increased system shipments to certain customers in Taiwan.

 

·       An approximate $0.5 million increase in depreciation expense and license fees.

 

·       Increased currency exchange losses of approximately $0.2 million.

 

These cost increases were partially offset by:

 

·       A $0.6 million decrease in salaries and benefits related to lower headcount and stock compensation costs.

 

·       Lower consulting costs of approximately $0.2 million.

 

·       Lower travel and supply costs of approximately $0.4 million related primarily to the implementation of Oracle 11i during fiscal 2007.

 

The increase in selling, general and administrative expense of approximately $3.2 million, or 13%, during the nine months ended June 27, 2008 over the nine months ended June 29, 2007 was primarily due to the following:

 

·       A $5.2 million increase in costs associated with pending legal matters.

 

·       Increases in costs associated with our international infrastructure build-up of $0.5 million.

 

·       A $0.4 million increase in depreciation expense related to the implementation of Oracle 11i, which was completed at the end of fiscal 2007.

 

·       A $0.2 million increase in bad debt expense.

 

These increases were partially offset by:

 

·       Lower salary, wages and employee benefits of approximately $1.3 million due primarily to lower headcount.

 

·       Approximately $0.2 million in reduced commission expenses related to lower system sales during the nine months ended June 27, 2008.

 

·       Lower travel costs of approximately $0.3 million due primarily to the implementation of Oracle 11i in 2007 and lower thermal system business levels in fiscal 2008.

 

·       A $0.4 million increase in currency transaction gains.

 

·       Approximately $0.3 million in reduced supplies expense due to the Oracle 11i implementation in fiscal 2007.

 

22



Table of Contents

 

Restructuring and Other Charges

 

 

 

Quarter Ended

 

Nine Months Ended

 

 

 

June 27,

 

June 29,

 

June 27,

 

June 29,

 

 

 

2008

 

2007

 

2008

 

2007

 

 

 

(dollars in thousands)

 

Restructuring and Other Charges

 

$

 

$

 

$

7,792

 

$

 

Percent of net sales

 

0

%

0

%

8

%

0

%

 

During the quarter ended March 28, 2008, we implemented restructuring plans to align operations with our core strength products in the ALD, Etch and PVD market segments. This entailed a downsizing of activities related to lower performing, less profitable products resulting in a global reduction in force, the write-down of impaired machinery and equipment and the divestiture of the net assets of ET Equipments Ltd., a machine shop located in Wales, U.K. During the quarter ended March 28, 2008, we also wrote down an intangible asset related to a license of certain technology. We have developed and successfully tested a more efficient and cost-effective technology thus impairing the asset.

 

The breakdown of restructuring and other charges included in operating expenses for the nine months ended June 27, 2008 are as follows (in thousands):

 

Impairment of machinery and equipment

 

$

3,854

 

Impairment of intagible asset

 

3,008

 

Loss on sale of net assets of ET Equipments LTD

 

543

 

Reduction in work force

 

387

 

 

 

$

7,792

 

 

Interest Expense

 

 

 

Quarter Ended

 

Nine Months Ended

 

 

 

June 27,

 

June 29,

 

June 27,

 

June 29,

 

 

 

2008

 

2007

 

2008

 

2007

 

 

 

(dollars in thousands)

 

Interest expense

 

$

487

 

$

663

 

$

1,435

 

$

2,978

 

Percent of net sales

 

1

%

1

%

1

%

2

%

 

Our interest expense for the quarters and nine months ended June 27, 2008 and June 29, 2007 consisted primarily of interest incurred on our revolving line of credit, equipment term loan and commercial real estate loan. In addition, amortization of debt issuance costs impacted both quarters. During the nine months ended June 29, 2007, interest expense included the amortization of the fair value of warrants issued to affiliates of VantagePoint in consideration of VantagePoint’s agreement to guarantee a portion of our prior revolving line of credit. During April 2007, we entered into a new financing agreement that did not require further guarantees. Unamortized debt issuance costs and warrant amortization related to the prior financing agreements were written off when the transaction for our new financing closed.

 

23



Table of Contents

 

Aggregate borrowings under our current revolving line of credit, equipment term loan and commercial real estate loan were $40.1 million at June 27, 2008 and $31.7 million at June 29, 2007.

 

During the quarter ended June 27, 2008, interest expense decreased by approximately $0.2 million from the quarter ended June 29, 2007, due primarily to lower average interest rates on our current credit facility. Interest rates on our current credit facility averaged 5.0% during the quarter ended June 27, 2008. Interest rates on our facilities in place during the quarter ended June 29, 2007 ranged from 7.75% to 10.625%.

 

During the nine months ended June 27, 2008, interest expense decreased by approximately $1.5 million from the nine months ended June 29, 2007 primarily due to lower average borrowings ($28.8 million average borrowings on our credit facility during the nine months ended June 27, 2008 as compared to $33.6 million average borrowings on our credit facilities in place during the nine months ended June 29, 2007), a lower average interest rate (6.0% as compared to 8.4%) and lower amortization of debt issuance costs ($0.1 million as compared to $0.6 million).

 

Income Taxes

 

Because we have incurred significant operating losses during prior periods, no material federal or state income taxes have been recorded. We recorded income taxes relating to certain profitable international subsidiaries and provided a full valuation allowance on our net tax benefits generated in all other jurisdictions during the respective periods.

 

Liquidity and Capital Resources

 

At June 27, 2008, our cash and cash equivalents were $11.8 million as compared to $23.1 million at September 28, 2007. This $11.3 million decrease in cash and cash equivalents is primarily attributable to cash used to fund operations ($19.8 million) and capital expenditures ($2.5 million) during the nine months ended June 29, 2008, which was partially offset by increased borrowings under our revolving line of credit.

 

We anticipate that our existing cash balances and available borrowings under our credit facility will be sufficient to meet our anticipated cash needs for at least the next 12 months. However, we may need to raise additional capital from the sale of debt or equity securities or from other sources in order to support our operations. We may not be able to obtain any additional capital on acceptable terms, if at all.

 

Cash Flows from Operating Activities

 

Operating activities used $19.8 million of cash in the nine months ended June 27, 2008. Cash was used to fund operating losses of $44.3 million during the nine months ended June 27, 2008. Non-cash operating costs totaling $23.6 million, consisting primarily of depreciation and amortization, restructuring and other charges and stock-based compensation, were included in the operating loss for the period. Cash provided by a decrease of $9.5 million in accounts receivable primarily due to collections of retentions due on shipments, a decrease of $1.2 million in prepaid expenses and other current assets and a $5.4 million increase in accrued liabilities primarily related to increased legal costs and restructuring charges was partially offset by cash used to fund increases in inventory of $10.9 million primarily related to increased PVD, Etch and CVD business opportunities, a decrease of $3.6 million in warranty liabilities primarily due to lower system shipments during the nine months ended June 27, 2008 and a decrease in accounts payable of $0.8 million due to the timing of inventory purchases.

 

Cash Flows from Investing Activities

 

Cash used in investing activities for the nine months ended June 27, 2008 was $1.6 million. Cash used in investing activities during the quarter primarily consisted of purchasing equipment to be used in our development and demonstration laboratories ($2.5 million), which was partially offset by proceeds received from the sale of equipment ($0.3 million) and the sale of the net assets of ET Equipments Ltd. ($0.6 million), our machine shop located in Wales, U.K.

 

Cash Flows from Financing Activities

 

Net cash generated by financing activities for the nine months ended June 27, 2008 was $10.6 million. Incremental bank borrowings under our revolving line of credit generated $13.1 million in cash. Payments on our equipment and mortgage lines of credit, short-term borrowings and capital lease obligations were the primary offsets to these borrowings.

 

24



Table of Contents

 

During April 2007, we entered into a credit facility with a syndicate of banks to refinance our previous line of credit and mortgage line of credit. Our credit facility includes a two-year revolving line of credit, an equipment term loan and a four-year commercial real estate term loan. We may borrow up to $55.0 million under our credit facility. Borrowings under the credit facility bear interest at the London Inter Bank Offering Rate, or LIBOR, plus 2.18% (4.64% at June 27, 2008). The terms of the credit agreement prohibits us from paying cash dividends on our common stock. The credit agreement contains certain financial and operating covenants.

 

Maximum borrowings available under the revolving line of credit are $44.0 million and are secured by our accounts receivable and inventory. Outstanding borrowings under the revolving line of credit were $26.0 million at June 27, 2008.

 

Maximum borrowings under the equipment term loan are $4.0 million and are secured by a lien on our equipment. Our equipment term loan has a three-year amortization period with monthly payments of principal and accrued interest. Outstanding borrowings under the equipment term loan were $2.6 million at June 27, 2008. As principal is paid down under the equipment portion of the facility, additional borrowing availability will be created under the revolving portion of the credit facility.

 

Maximum borrowings under the commercial real estate term loan are $13.0 million or 70% of the appraised value of the real estate, whichever is lower, and are secured by a deed of trust on our Scotts Valley facility. Monthly payments of principal and accrued interest will be based on a 20-year amortization period of the loan principal. Outstanding borrowings under the commercial real estate term loan were $11.5 million at June 27, 2008. As principal is paid down under the commercial real estate portion of the facility, additional borrowing availability will be created under the revolving portion of the credit facility.

 

A subsidiary of ours has a revolving line of credit for 200,000,000 Japanese Yen (approximately $1.9 million, at the exchange rate on June 27, 2008) under which there were no borrowings at June 27, 2008. The credit line bears interest at 1.875% per annum.

 

Off-Balance Sheet Arrangements

 

At June 27, 2008, we had no off-balance sheet arrangements as defined in Item 303(a)(4) of Regulation S-K promulgated by the Securities and Exchange Commission.

 

Contractual Obligations

 

Other than operating leases for certain equipment and real estate and certain vendor commitments, we have no significant off-balance sheet transactions or unconditional purchase obligations. As a “smaller reporting company,” we are not required to provide tabular disclosure of contractual obligations.

 

ITEM 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK

 

As a “smaller reporting company,” we are not required to provide the information required by this Item.

 

ITEM 4. CONTROLS AND PROCEDURES

 

An evaluation was performed under the supervision and with the participation of our management, including our chief executive officer and chief financial officer, of the effectiveness of the design and operation of our disclosure controls and procedures as of the end of the period covered by this quarterly report. Based on that evaluation, our management, including our chief executive officer and chief financial officer, concluded that, as of June 27, 2008, our disclosure controls and procedures were effective. During the nine months ended June 27, 2008, there were no changes in our internal control over financial reporting that materially affected, or were reasonably likely to materially affect, our internal control over financial reporting.

 

25



Table of Contents

 

PART II. OTHER INFORMATION

 

ITEM 1. LEGAL PROCEEDINGS

 

On April 11, 2006, IPS, Ltd. filed a lawsuit against us in the United States District Court for the Central District of California. The complaint alleges that we improperly used IPS’s confidential information to develop our Celsior single-wafer processing type atomic layer deposition technology. The complaint is for unspecified monetary damages, injunctive relief and an order rescinding the settlement and distributor agreements that we and IPS entered into in May 2004 in settlement of a prior lawsuit that IPS filed against ASML U.S., Inc. and us in March 2004 relating to assets that we acquired from ASML in October 2003. In May 2007, we successfully moved the dispute to arbitration. Discovery commenced in June 2007. The arbitration hearing is currently scheduled for March 2009. We intend to contest the lawsuit vigorously. We do not believe that the outcome of this lawsuit will have a material impact on our business, financial condition or results of operations.

 

Prior to our merger transaction with Trikon Technologies, Inc., Trikon was a party to an employment lawsuit in France. On March 10, 2004, Dr. Jihad Kiwan departed Trikon as Director and Chief Executive Officer. On March 29, 2004 and April 2, 2004, Trikon received letters from a United Kingdom law firm and from a French law firm, respectively, on behalf of Dr. Kiwan, detailing certain monetary claims for severance amounts due to Dr. Kiwan with respect to his employment with Trikon. On April 28, 2004, Dr. Kiwan filed a lawsuit in France and on June 10, 2004, filed similar proceedings in the United Kingdom. Dr. Kiwan has subsequently withdrawn the proceedings in the United Kingdom. On January 7, 2008, the French Commercial Court in Grenoble rejected certain of Dr. Kiwan’s claims but ordered us to pay monetary awards with respect to certain other of Dr. Kiwan’s claims. We have appealed the decision and do not believe that the outcome of the dispute will have a material impact on our business, financial condition or results of operations . We have accrued our estimate of the cost to settle the claims at June 27, 2008.

 

On December 1, 2006, we filed an arbitration demand against ASML U.S., Inc., and related entities, asserting claims of fraud, negligent misrepresentation, fraud in the inducement and breach of the covenant of good faith and fair dealing arising out of our purchase of ASML’s Thermal Division in October 2003. Following discovery and an unsuccessful motion for summary judgment filed by ASML, the matter was arbitrated in December 2007 and January 2008. The arbitrator issued a preliminary judgment in favor of ASML. Based on a provision in the governing contract providing that the party prevailing in the arbitration may recover its attorneys’ fees and costs from the opposing party, the arbitrator has ordered briefing by both parties with regard to any fee request by ASML. On April 17, 2008, ASML submitted a petition seeking approximately $2.5 million in attorneys’ fees and costs incurred in connection with this matter. Following full briefing by both parties, the arbitrator issued a final award of approximately $1.4 million in attorneys’ fees and costs to ASML. We have accrued our estimate of the cost to settle the claims at June 27, 2008.

 

ITEM 1A. RISK FACTORS

 

As a “smaller reporting company,” we are not required to provide the information required by this Item.

 

ITEM 2. UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS

 

None.

 

ITEM 3. DEFAULTS UPON SENIOR SECURITIES

 

None.

 

ITEM 4. SUBMISSION OF MATTERS TO A VOTE OF SECURITY HOLDERS

 

None

 

26



Table of Contents

 

ITEM 5. OTHER INFORMATION

 

None.

 

ITEM 6. EXHIBITS

 

Exhibit
Number

 

Description

 

 

 

31.1

 

Certification of the Chief Executive Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.

 

 

 

31.2

 

Certification of the Chief Financial Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.

 

 

 

32.1

 

Certification of the Chief Executive Officer pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.

 

 

 

32.2

 

Certification of the Chief Financial Officer pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.

 

27



Table of Contents

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

 

 

Aviza Technology, Inc.

 

(Registrant)

 

 

Dated: August 6, 2008

 

 

By:

/s/ PATRICK C. O’CONNOR

 

 

 

Patrick C. O’Connor

 

Executive Vice President and Chief Financial

 

Officer

 

(Principal Financial and Accounting Officer)

 

28



Table of Contents

 

EXHIBIT INDEX

 

Exhibit
Number

 

Description

 

 

 

31.1

 

Certification of the Chief Executive Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.

 

 

 

31.2

 

Certification of the Chief Financial Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.

 

 

 

32.1

 

Certification of the Chief Executive Officer pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.

 

 

 

32.2

 

Certification of the Chief Financial Officer pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.

 

29


Aviza Tech (MM) (NASDAQ:AVZA)
Gráfico Histórico do Ativo
De Mai 2024 até Jun 2024 Click aqui para mais gráficos Aviza Tech (MM).
Aviza Tech (MM) (NASDAQ:AVZA)
Gráfico Histórico do Ativo
De Jun 2023 até Jun 2024 Click aqui para mais gráficos Aviza Tech (MM).